Log in to save to my catalogue

Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China

Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_212e03fb85ba422f9291944bfe8334b7

Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China

About this item

Full title

Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China

Publisher

United States: Taylor & Francis Ltd

Journal title

Emerging microbes & infections, 2024-12, Vol.13 (1), p.2398596

Language

English

Formats

Publication information

Publisher

United States: Taylor & Francis Ltd

More information

Scope and Contents

Contents

The global rate of Amphotericin B (AmB) resistance in
has surpassed 12%. However, there is limited data on available clinical treatments and microevolutionary analyses concerning reduced AmB sensitivity. In this study, we collected 18
isolates from five patients between 2019 and 2022. We employed clinical data mining, genomic, and transcripto...

Alternative Titles

Full title

Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_212e03fb85ba422f9291944bfe8334b7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_212e03fb85ba422f9291944bfe8334b7

Other Identifiers

ISSN

2222-1751

E-ISSN

2222-1751

DOI

10.1080/22221751.2024.2398596

How to access this item